Janus Schou Jakobsen (Janus S Jakobsen)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Science advances

Nature cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Meldgaard Hansen, Ying Ge, Mikkel Bruhn Schuster, Sachin Pundhir, Janus Schou Jakobsen, Adrija Kalvisa, Marta Cecylia Tapia, Sandra L Gordon, Francesca Ambri, Frederik Otzen Bagger, Deo Pandey, Kristian Helin, Bo Torben Porse
H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway. Science advances 8 (11) (2022)
Janus Schou Jakobsen, Linea G Laursen, Mikkel Bruhn Schuster, Sachin Pundhir, Erwin M Schoof, Ying Ge, Teresa d'Altri, Kristoffer Vitting-Seerup, Nicolas Rapin, Coline Gentil, Johan Jendholm, Kim Theilgaard-Mönch, Kristian Reckzeh, Lars Bullinger, Konstanze Döhner, Peter Hokland, Jude Fitzgibbon, Bo Torben Porse
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML. Science advances 5 (7) (2019)
Bruno Di Stefano, Samuel Collombet, Janus Schou Jakobsen, Michael Wierer, Jose Luis Sardina, Andreas Lackner, Ralph Stadhouders, Carolina Segura-Morales, Mirko Francesconi, Francesco Limone, Matthias Mann, Bo Torben Porse, Denis Thieffry, Thomas Graf
C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4. Nature cell biology 18 (4) (2016)